Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.47 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | GJB2 | P29033 | 1/20 | 0.38 |
| ▸ | TACR2 | P21452 | 2/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 9/20 | 0.37 |
| ▸ | PTPN2 | P17706 | 6/20 | 0.36 |
| ▸ | PTPN6 | P29350 | 6/20 | 0.36 |
| ▸ | PTPN11 | Q06124 | 6/20 | 0.36 |
| ▸ | CDC25B | P30305 | 6/20 | 0.36 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24059833 | 1.00 | NT5E (0.47) | NT5ELGALS3MAOBGJB2TACR2 | |
| SCHEMBL18394464 | 1.00 | NT5E (0.47) | NT5ELGALS3MAOBGJB2TACR2 | |
| SCHEMBL17087715 | 0.87 | LGALS3 (0.39) | NT5ELGALS3MAOBGJB2PTPN1 | |
| SCHEMBL18412650 | 0.87 | LGALS3 (0.41) | NT5ELGALS3GJB2PTPN1PTPN2 | |
| SCHEMBL18394344 | 0.87 | LGALS3 (0.41) | NT5ELGALS3GJB2PTPN1PTPN2 | |
| SCHEMBL20243568 | 0.87 | LGALS3 (0.41) | NT5ELGALS3GJB2PTPN1PTPN2 | |
| SCHEMBL18412635 | 0.85 | LGALS3 (0.38) | NT5ELGALS3GJB2TACR2PTPN1 | |
| SCHEMBL22013737 | 0.84 | FGF2 (0.43) | NT5ELGALS3GJB2PTPN1PTPN2 | |
| SCHEMBL19891479 | 0.82 | NT5E (0.54) | NT5EMAOBGJB2TACR2PTPN1 | |
| SCHEMBL19891476 | 0.82 | NT5E (0.54) | NT5EMAOBGJB2TACR2PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11220523-B2 | Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein | UNIVERSITÄT BASEL (CH) | 2022-01-11 | — | — | US | disclosed |
| EP-3116887-B1 | CARBOHYDRATE LIGANDS THAT BIND TO IGM ANTIBODIES AGAINST MYELIN-ASSOCIATED GLYCOPROTEIN | UNIV BASEL (CH) | 2021-02-17 | — | — | EP | disclosed |
| US-10662212-B2 | Carbohydrate ligands that bind to IGM antibodies against myelin-associated glycoprotein | UNIVERSITAT BASEL (CH) | 2020-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11220523-B2 | Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein | MAG, PMP22, SIGLEC7 | NT5E 1595/4885LGALS3 84/4885MAOB 4335/4885 |
| US-10662212-B2 | Carbohydrate ligands that bind to IGM antibodies against myelin-associated glycoprotein | MAG, PMP22, SIGLEC7 | NT5E 1622/4885LGALS3 87/4885MAOB 4290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.